[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Atrial Fibrillation: Technologies and Global Markets

October 2018 | 120 pages | ID: ADF967B2C66EN
BCC Research

US$ 1,250.00 US$ 2,500.00 -50 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Scope:

The report on Atrial Fibrillation: Technologies and Global Markets covers interventional procedural products, namely Cardiac Ablation products and Left Atrial Appendage closure devices.

Devices included as a part of market estimates are:
  • Catheter ablation products, including electrophysiology ablation catheters, electrophysiology diagnostic catheters, lab systems (3D electro-anatomical mapping systems, robotic catheter navigation systems, intracardiac echocardiography systems, recording systems, ablation generators and irrigation pumps), access devices and consumables.
  • Left atrial appendage closure devices, including all occlusion device systems and implantable devices employed in endocardial and epicardial LAA procedures, which include cardiac plugs, clips and suture delivery systems.

    Devices excluded from market estimates are:
  • Pharmacological drugs employed in standalone and combination of ablation procedures.
  • Devices like defibrillators and preliminary diagnostic devices, including cardiac monitors and Holter monitors (including implantable Holter monitors).
  • ECG machines and consumables, wearable devices, implantable loop recorders (ILR), pacemakers, and electrical cardioversion devices.
  • Further surgical ablation products employed in Cox-Maze IV or Mini-Maze surgery and thoracoscopy visualization devices.
  • Imaging systems such as Rotational angiography, fluoroscopy X-ray systems, CT and MRI imaging systems.

    The report covers the market dynamics and trends that are shaping the atrial fibrillation treatment interventions. Other subjects discussed in the report are key qualitative factors like epidemiology, categories of atrial fibrillation, key device development and regulations.

    The market landscape of atrial fibrillation was studied at a regional level covering North America, Europe, Asia-Pacific and Other markets. Profiles of key leading companies engaged in the marketing and development of atrial fibrillation devices are covered, with additional information on the market position of major companies in the atrial fibrillation market.

    Report Includes::
    • 25 data tables and 13 additional tables
    • An overview of the global market for atrial fibrillation and technologies
    • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
    • Detailed description of the market for drug treatment, surgical intervention, and other aspects of atrial fibrillation
    • Discussion of the types of atrial fibrillation treatment
    • A look into various government regulations
    • Insight into the emerging developmental technologies and clinical trials for new technology for atrial fibrillation
    • Company profiles of the manufacturers of surgical equipment, surgical accessories, and pharmaceuticals, including Abbott Laboratories, Aegis Medical Innovations, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic and Philips Healthcare
  • CHAPTER 1 INTRODUCTION

    Study Goals and Objectives
    Reasons for Doing this Study
    Scope of Report
    Methodology
    Geographic Breakdown
    Analyst's Credentials
    BCC Custom Research
    Related BCC Research Reports

    CHAPTER 2 SUMMARY AND HIGHLIGHTS

    CHAPTER 3 BACKGROUND

    Heart Structure and Function
    Cardiac Arrhythmia
    Treadmill Run Test Stress Test
    Holter Monitoring
    Echocardiography
    Electrophysiologic Testing
    Atrial Fibrillation (AFib)
    Symptoms
    Global Epidemiology
    Economic Burden of Atrial Fibrillation
    Risk Factors
    Complications of Atrial Fibrillation
    Patterns of Atrial Fibrillation
    Current Standard of Care for Atrial Fibrillation
    Diagnosis
    Treatment of AFib

    CHAPTER 4 MARKET OVERVIEW

    Market Dynamics
    Market Drivers
    Market Restraints
    Emerging Trends
    Regulatory Landscape
    Regulation in Europe
    Regulation in the U.S.
    Regulation in Japan
    Regulation in China
    Regulation in India

    CHAPTER 5 MARKET BREAKDOWN BY DEVICE TYPE

    Introduction and Global Markets
    Catheter Ablation Devices
    Overview
    Market Size and Forecast
    Catheter Ablation Devices by Type
    Left Atrial Appendage (LAA) Closure Devices
    Overview
    Cost Benefits of Left Atrial Appendage Closure Devices vs. Pharmacological Therapy
    Market Size and Forecast
    Types of Left Atrial Appendage Implantation

    CHAPTER 6 MARKET BREAKDOWN BY REGION

    Introduction
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    Asia-Pacific
    China
    Japan
    India
    Rest of the World

    CHAPTER 7 COMPETITIVE LANDSCAPE AND RECENT   DevelopmentS

    Market Share Analysis
    Atrial Fibrillation: Company Market Share Analysis
    Strategies Adopted by Market Leaders
    Catheter Ablation Devices: Company Market Share Analysis
    Left Atrial Appendage Closure Devices: Company Market Share Analysis
    Barriers to the Entry for New Players
    High Degree of Competitiveness
    Product Portfolio Analysis
    Catheter Ablation Devices Product Portfolio Analysis
    Left Atrial Appendage Closure Devices Product Portfolio Analysis
    Key Recent Industry Events

    CHAPTER 8 COMPANY PROFILES

    ABBOTT LABORATORIES
      Company Overview
      Financials
    Atrial Fibrillation Business
    Product Portfolio
      Development and Strategies
    ABLACOR MEDICAL CORP.
      Company Overview
    ACUTUS MEDICAL INC
      Company Overview
    AEGIS MEDICAL INNOVATIONS
      Company Overview
    AFREEZE GMBH
      Company Overview
    AURIS HEALTH (HANSEN MEDICAL)
      Company Overview
    ATRICURE INC
      Company Overview
      Financials
    Business of Atrial Fibrillation
    Product Portfolio
    BIOTRONIK
      Company Overview
    BOSTON SCIENTIFIC
      Company Overview
      Financials
    Product Portfolio
    CARDIOFOCUS
      Company Overview
    CATHRX
      Company Overview
    GE HEALTHCARE
      Company Overview
      Financials
    JOHNSON & JOHNSON
      Company Overview
      Financials
    Business of Atrial Fibrillation
    Product Portfolio
    KARDIUM
      Company Overview
    LIFETECH SCIENTIFIC CORP.
      Company Overview
    LUXCATH
      Company Overview
    MEDTRONIC
      Company Overview
      Financials
    Product Portfolio
    MICROPORT SCIENTIFIC CORP.
      Company Overview
      Financials
    PHILIPS HEALTHCARE
      Company Overview
      Financials
    SENTREHEART
      Company Overview
    STEREOTAXIS
      Company Overview

    CHAPTER 9 APPENDIX: ACRONYMS

    LIST OF TABLES

    Summary Table: Global Market for Atrial Fibrillation Devices, by Type, Through 2023
    Table 1: Breakdown of U.S. Cost Burden of Cardiovascular Disease, 2015 and 2035
    Table 2: Breakdown of U.S. Cost Burden of Cardiovascular Diseases, by Type 2015 and 2035
    Table 3: Complications of Catheter Ablations and Incidence Rates, 2016
    Table 4: Cardiology Workforce Demand and Supply Trends, by Cardiac Subspecialty, 2009
    Table 5: Catheter Ablation and Left Atrial Appendage Closure Device Approvals, 2015-2018
    Table 6: Global Market for Atrial Fibrillation Devices, by Major Segment, Through 2023
    Table 7: Global Market for Catheter Ablation Devices, by Region, Through 2023
    Table 8: Global Market for Catheter Ablation Devices, by Type, Through 2023
    Table 9: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
    Table 10: Global Market for Electrophysiology Diagnostic Catheters, by Region, Through 2023
    Table 11: Global Market for Lab Systems, by Region, Through 2023
    Table 12: Global Market for Access Devices, by Region, Through 2023
    Table 13: Cost Benefit Analysis of Left Atrial Appendage Closure vs. Anticoagulant Drugs
    Table 14: Global Market for Left Atrial Appendage Closure Devices, by Region, Through 2023
    Table 15: Global Market for Left Atrial Appendage Closure Devices, by Type, Through 2023
    Table 16: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, Through 2023
    Table 17: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, Through 2023
    Table 18: Global Market for Atrial Fibrillation Devices, by Region, Through 2023
    Table 19: North American Market for Atrial Fibrillation Devices, by Country, Through 2023
    Table 20: European Market for Atrial Fibrillation Devices, by Country, Through 2023
    Table 21: Asia-Pacific Market for Atrial Fibrillation Devices, by Country, Through 2023
    Table 22: Product Portfolio Analysis
    Table 23: Catheter Ablation Devices Market: Company Portfolio Comparison
    Table 24: Left Atrial Appendage Closure Devices Market: Company Portfolio Comparison
    Table 25: Key Industry Events in the Atrial Fibrillation Device Market, January 2015-July 2018
    Table 26: Abbott Laboratories: Net Revenue, 2015-2017
    Table 27: Abbott Laboratories: Products
    Table 28: AtriCure: Net Revenue, 2015-2017
    Table 29: AtriCure: Products
    Table 30: Boston Scientific: Net Revenue, 2015-2017
    Table 31: Boston Scientific: Products
    Table 32: Johnson & Johnson: Net Revenue, 2015-2017
    Table 33: Johnson & Johnson (Biosense Webster): Products and Services
    Table 34: Medtronic: Net Revenue, 2015-2017
    Table 35: Medtronic: Products
    Table 36: MicroPort: Net Revenue, 2015-2017
    Table 37: Sterotaxis: Net Revenue, 2015-2017
    Table 38: Acronyms Used in Atrial Fibrillation

    LIST OF FIGURES

    Summary Figure: Global Market for Atrial Fibrillation Devices, by Type, 2016-2023
    Figure 1: Prevalence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
    Figure 2: Incidence Rates of Atrial Fibrillation in Developed and Developing Countries, by Gender, 2010
    Figure 3: Trends in Inpatient Stays of Atrial Fibrillation Affected Patients, by Age Group, 2014
    Figure 4: Atrial Fibrillation Market Dynamics
    Figure 5: Trends in World Aging Population, 2017 and 2050
    Figure 6: AFib Population Trends for the U.S. and Europe, 2010 and 2050
    Figure 7: Global Market for Atrial Fibrillation Devices, by Major Segment, 2016-2023
    Figure 8: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2017
    Figure 9: Global Market Share for Atrial Fibrillation Devices, by Major Segment, 2023
    Figure 10: Global Market for Catheter Ablation Devices, 2016-2023
    Figure 11: Global Market for Catheter Ablation Devices, by Region, 2016-2023
    Figure 12: Global Market Share for Catheter Ablation Devices, by Region, 2017
    Figure 13: Global Market Share for Catheter Ablation Devices, by Region, 2023
    Figure 14: Global Market for Catheter Ablation Devices, by Type, 2016-2023
    Figure 15: Global Market Share for Catheter Ablation Devices, by Type, 2017
    Figure 16: Global Market Share for Catheter Ablation Devices, by Type, 2023
    Figure 17: Global Market for Electrophysiology Ablation Catheters, 2016-2023
    Figure 18: Global Market for Electrophysiology Ablation Catheters, by Region, Through 2023
    Figure 19: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2017
    Figure 20: Global Market Share for Electrophysiology Ablation Catheters, by Region, 2023
    Figure 21: Global Market for Electrophysiology Diagnostic Catheters, 2016-2023
    Figure 22: Global Market for Electrophysiology Diagnostic Catheters, by Region, 2016-2023
    Figure 23: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2017
    Figure 24: Global Market Share for Electrophysiology Diagnostic Catheters, by Region, 2023
    Figure 25: Global Market for Lab Systems, 2016-2023
    Figure 26: Global Market for Lab Systems, by Region, 2016-2023
    Figure 27: Global Market Share for Lab Systems, by Region, 2017
    Figure 28: Global Market Share for Lab Systems, by Region, 2023
    Figure 29: Global Market for Access Devices, 2016-2023
    Figure 30: Global Market for Access Devices, by Region, 2016-2023
    Figure 31: Global Market for Left Atrial Appendage Closure Devices, 2016-2023
    Figure 32: Global Market for Left Atrial Appendage Closure Devices, by Region, 2016-2023
    Figure 33: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2017
    Figure 34: Global Market Share for Left Atrial Appendage Closure Devices, by Region, 2023
    Figure 35: Global Market for Left Atrial Appendage Closure Devices, by Type, 2016-2023
    Figure 36: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2017
    Figure 37: Global Market Share for Left Atrial Appendage Closure Devices, by Type, 2023
    Figure 38: Global Market for Endocardial Left Atrial Appendage Closure Devices, 2016-2023
    Figure 39: Global Market for Endocardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
    Figure 40: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2017
    Figure 41: Global Market Share for Endocardial Left Atrial Appendage Closure Devices, by Region, 2023
    Figure 42: Global Market for Epicardial Left Atrial Appendage Closure Devices, 2016-2023
    Figure 43: Global Market for Epicardial Left Atrial Appendage Closure Devices, by Region, 2016-2023
    Figure 44: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2017
    Figure 45: Global Market Share for Epicardial Left Atrial Appendage Closure Devices, by Region, 2023
    Figure 46: North American Market for Atrial Fibrillation Devices, 2016-2023
    Figure 47: European Market for Atrial Fibrillation Devices, 2016-2023
    Figure 48: Asia-Pacific Market for Atrial Fibrillation Devices, 2016-2023
    Figure 49: RoW Market for Atrial Fibrillation Devices, 2016-2023
    Figure 50: Global Market Share for Atrial Fibrillation Devices, by Company, 2017
    Figure 51: Global Market Share for Catheter Ablation Devices, by Company, 2017
    Figure 52: Global Market Share for Atrial Appendage Closure Devices, by Company, 2017
    Figure 53: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
    Figure 54: Abbott Laboratories: Revenue, by Country, 2015-2017
    Figure 55: Abbott Laboratories: Revenue Share, by Cardiology Segment, 2015-2017
    Figure 56: AtriCure: Revenue, by Product Segment, 2015-2017
    Figure 57: AtriCure: Revenue Share, by Region/Country, 2017
    Figure 58: Boston Scientific: Revenue, by Business Segment, 2015-2017
    Figure 59: Boston Scientific: Revenue Share, by Business Segment, 2017
    Figure 60: GE Healthcare: Annual Revenue, 2015-2017
    Figure 61: GE Healthcare: Revenue Share, by Region, 2017
    Figure 62: GE Healthcare: Revenue Share, by Product Division, 2017
    Figure 63: Johnson & Johnson: Revenue Share, by Business Segment, 2017
    Figure 64: Johnson & Johnson: Revenue Share, by Medical Device Segment, 2017
    Figure 65: Medtronic: Revenue, by Business Segment, 2015-2017
    Figure 66: Medtronic: Revenue Share, by Business Segment, 2017
    Figure 67: Philips Sales Revenue, 2015-2017
    Figure 68: Philips Sales Revenue Share, by Business Unit, 2016
    Figure 69: Philips Sales Revenue Share, by Business Unit, 2017
    Figure 70: Stereotaxis: Revenue, by Business Segment, 2015-2017


    More Publications